Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Share-based Compensation (2023 - 2025)

SeaStar Medical Holding's Share-based Compensation history spans 3 years, with the latest figure at -$256000.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 220.75% year-over-year to -$256000.0; the TTM value through Dec 2025 reached $298000.0, down 66.4%, while the annual FY2025 figure was $298000.0, 66.4% down from the prior year.
  • Share-based Compensation reached -$256000.0 in Q4 2025 per ICUCW's latest filing, down from $290000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $555000.0 in Q2 2023 to a low of -$256000.0 in Q4 2025.
  • Average Share-based Compensation over 3 years is $259583.3, with a median of $251000.0 recorded in 2024.
  • The largest YoY upside for Share-based Compensation was 136.59% in 2025 against a maximum downside of 220.75% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $386000.0 in 2023, then tumbled by 45.08% to $212000.0 in 2024, then plummeted by 220.75% to -$256000.0 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Share-based Compensation are -$256000.0 (Q4 2025), $290000.0 (Q3 2025), and $97000.0 (Q2 2025).